Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04463771 | Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.(POD1UM-204) | completed | Phase 2 | 206 | Incyte CorporationINDUSTRY | 7 | Jun 11, 2026 | clinicaltrials |
| NCT06647992 | Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65 | completed | N/A | 80 | TURKAN OZDASOTHER | 1 |
| Jun 9, 2026 |
| clinicaltrials |
| NCT05682950 | Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer | completed | Phase 2 | 15 | Peking Union Medical College HospitalOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT07626996 | Laparoscopic Versus Open Radical Hysterectomy in Early-Stage Cervical Cancer(LAP-OPEN) | completed | N/A | 60 | Zagazig UniversityOTHER_GOV | 1 | Jun 4, 2026 | clinicaltrials |
| NCT00951496 | Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | completed | Phase 3 | 1,560 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2026 | clinicaltrials |
| NCT00002968 | Edrecolomab in Treating Patients With Stage II Colon Cancer | completed | Phase 3 | 2,100 | National Cancer Institute (NCI)NIH | 1 | Jun 1, 2026 | clinicaltrials |
| NCT06259448 | Feasibility of Optimizing Organized Cervical Cancer Screening by Urine Self-sampling(PAPPEES) | completed | N/A | 173 | University Hospital, BordeauxOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT04345003 | MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids(ELASTUS) | completed | N/A | 40 | University Hospital, BordeauxOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06106165 | Improving Muslim Women's Uptake of Cancer Screening (IMCAN)(IMCAN) | completed | N/A | 169 | University of SunderlandOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07612865 | People's Hospital of Xinjiang Uygur Autonomous Region | completed | N/A | 160 | People's Hospital of Xinjiang Uygur Autonomous RegionOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT02755844 | Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients(ENDOLA) | completed | Phase 1 / Phase 2 | 35 | Hospices Civils de LyonOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06010160 | Game Changers for Cervical Cancer Prevention(GC-CCP) | completed | N/A | 936 | RANDOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06102252 | Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma | completed | N/A | 60 | Sohag UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT04008095 | Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer(COLTEP) | completed | — | 40 | University Hospital, BrestOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT02386137 | Factors Influencing Volumetric MR-HIFU Ablation of Uterine Fibroids(PERAGUS) | completed | N/A | 40 | University Hospital, BordeauxOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT05409872 | Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids(DEFIB) | completed | N/A | 108 | Universita di VeronaOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07547267 | The Effect of Vaginal Dilator Use | completed | N/A | 80 | Istanbul Aydın UniversityOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT04185389 | Long-Term Follow-Up of HPV FOCAL Participants(HPV FOCAL) | completed | — | 1,710 | University of British ColumbiaOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT05156268 | A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT04716127 | A Proximity-incentive Strategy for Cervical Cancer Screening(RIDECA) | completed | N/A | 656 | University Hospital, MontpellierOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT03556839 | Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix(BEATcc) | completed | Phase 3 | 410 | Grupo Español de Investigación en Cáncer de OvarioOTHER | 8 | Apr 21, 2026 | clinicaltrials |
| NCT03935282 | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors(AH-HA) | completed | N/A | 645 | Wake Forest University Health SciencesOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT05489978 | Effectiveness of a Cervical Cancer Stigma Reduction Intervention Program on Cancer Stigma Score and Cervical Cancer Screening Uptake in Nepal | completed | N/A | 310 | Kathmandu University School of Medical SciencesOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT05132114 | Large Loop Excision of the Transformation Zone (LLETZ) With vs Without IntraOperative Application of Lugol's Iodine(LLETZ-IOLI) | completed | N/A | 230 | Ruhr University of BochumOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT03115398 | A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery | completed | N/A | 166 | Montefiore Medical CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT03555422 | Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO](ENGOT-EN5) | completed | Phase 3 | 263 | Karyopharm Therapeutics IncINDUSTRY | 10 | Apr 13, 2026 | clinicaltrials |
| NCT03694262 | The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)(EndoBARR) | completed | Phase 2 | 30 | Medical College of WisconsinOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05461430 | Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)(TraveraRTGx) | completed | — | 72 | Travera IncINDUSTRY | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05651282 | Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer(RESToRE) | completed | Phase 4 | 96 | University of British ColumbiaOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06973161 | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors | completed | — | 140 | AstraZenecaINDUSTRY | 12 | Apr 8, 2026 | clinicaltrials |
| NCT01989923 | Smoking Cessation in Women With Gynecological Conditions | completed | N/A | 31 | University of OklahomaOTHER | 1 | Apr 7, 2026 | clinicaltrials |
| NCT03612791 | Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab(ATEZOLACC) | completed | Phase 2 | 189 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT06919627 | Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)(PaPCR) | completed | — | 45 | University Hospital, BrestOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT04122235 | The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study(LETSGO) | completed | N/A | 755 | Sorlandet Hospital HFOTHER_GOV | 1 | Mar 30, 2026 | clinicaltrials |
| NCT02122185 | Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 2 | 111 | University of ChicagoOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT02865837 | Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer(VESICOL) | completed | N/A | 22 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT03617679 | Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer | completed | Phase 2 | 79 | University of Colorado, DenverOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT04557423 | Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening | completed | N/A | 797 | Fox Chase Cancer CenterOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06662435 | GYNecologic Cancer-Related COGnitive Impairment(GYNCOG) | completed | N/A | 60 | Northwestern UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT06036836 | Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010) | completed | Phase 2 | 163 | Merck Sharp & Dohme LLCINDUSTRY | 10 | Mar 19, 2026 | clinicaltrials |
| NCT04814108 | A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma | completed | Phase 2 | 92 | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncINDUSTRY | 4 | Mar 18, 2026 | clinicaltrials |
| NCT01303094 | Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma(T-DIS) | completed | Phase 2 | 53 | Centre Oscar LambretOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT01247779 | Perioperative Morbidity in Gyneco-oncology According to the Procedure : Coelioscopy Versus Robot-assisted Coelioscopy(ROBO-GYN) | completed | N/A | 386 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT03315351 | Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer(TEP-Curie) | completed | N/A | 14 | Centre Oscar LambretOTHER | 1 | Mar 13, 2026 | clinicaltrials |
| NCT04300647 | A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer(SKYSCRAPER-04) | completed | Phase 2 | 172 | Hoffmann-La RocheINDUSTRY | 17 | Mar 12, 2026 | clinicaltrials |
| NCT04341883 | Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer | completed | Phase 2 | 27 | Sun Yat-sen UniversityOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT02858310 | E7 TCR T Cells for Human Papillomavirus-Associated Cancers | completed | Phase 1 / Phase 2 | 224 | National Cancer Institute (NCI)NIH | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04423679 | The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples(SELFIE) | completed | — | 294 | George Washington UniversityOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT06184867 | Choices About Genetic Testing And Learning Your Risk With Smart Technology(CATALYST) | completed | N/A | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 6, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jun 11, 2026source: clinicaltrials